drugset / Trial / NCT01818258

Summary

Children living with HIV from sub-Saharan Africa often present with severe malnutrition. In severe malnutrition, metabolic and/or gut structural derangement may lead to inadequate antiretroviral (ARV) absorption and/or erratic drug levels. The greater surface area to weight ratio in severely malnourished children could also place them at higher risk of under dosing compared to children with mild to moderate malnutrition. However, limited data are available on the pharmacokinetics of ARVs in severely malnourished children. This study addressed this critical gap in knowledge by evaluating the PK of zidovudine (ZDV), lamivudine (3TC), and lopinavir/ritonavir (LPV/r) in severely malnourished children living with HIV, compared to children with normal nutrition to mild malnutrition living with HIV.

Timeline

Start
2015-10-26
Primary completion
2017-04-11
Completion
2017-09-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lamivudine Other / unclassified 10 mg/ml Oral
Comparator Lopinavir/ritonavir Unknown 20 mg/ml Oral
Comparator Lopinavir/ritonavir Unknown 80 mg/ml Oral
Comparator Zidovudine Small molecule 10 mg/ml Oral